2nd Quarter - Report

DANAHER CORPORATION for DANAHER CORPORATION

Period 2nd Quarter 2026 Filed Jul 20, 2026 Signed by Mayealie Adams

Official filing
Firm
DANAHER CORPORATION
Client
DANAHER CORPORATION
Income
—
Expenses
$200,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to biotechnology, cell and gene therapy

LobbyistCovered position, as disclosed
MAYEALIE ADAMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Tariff (miscellaneous tariff bills) TAR

General issues related to tariffs

LobbyistCovered position, as disclosed
MAYEALIE ADAMS —

Contacted: Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; U.S. Trade Representative (USTR); SENATE

Environment/Superfund ENV

Issues related to decarbonization

LobbyistCovered position, as disclosed
MAYEALIE ADAMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.